.jpg)
.png)
Q: How did your career path lead you to the Department of Veterans Affairs, and what does it mean to you to apply your knowledge and experience to the health and well-being of current and former servicemen and women?
Article By:
VA Western NY Health Care Center
Buffalo, New York
Diplomate, Accreditation Council for Clinical Lipidology
A primary mission of the National Lipid Association (NLA) is to invigorate interest in lipidology-based prevention strategies amongst the healthcare community and the public at-large. Through diverse leadership direction and innovation, the Northeast Lipid Association (NELA) is having a successful year in achieving this mission regionally and nationally. We are excited by our members’ ability to educate and engage the public as we endeavor to bring lipids into the spotlight.
Article By:
Director, Preventive Cardiology
North Shore Hospital
Northwell Health
Manhassett, NY
Diplomate, American Board of Clinical Lipidology
Cardiovascular disease (CVD) remains the leading cause of death for women in the United States.(1) Unique factors affecting a woman’s health contribute significantly to CVD risk, but historically were not always represented in major guidelines. Some of these factors include hormonal changes, the presence of genderspecific risk factors and comorbidities more frequently seen in women (e.g. rheumatoid arthritis and systemic lupus erythematosus).
Article By:
Preventive Cardiology Fellow
Lenox Hill Hospital
New York, NY
Director, Preventive Cardiology & Lipid Clinic
Division of Cardiology
Bassett Medical Center
Cooperstown, NY
System Director, Cardiovascular Prevention
Northwell Health
Director, Women’s Heart Health
Lenox Hill Hospital
New York, NY
In October 2018, the American College of Cardiology (ACC) and the American Heart Association (AHA), in collaboration with the National Lipid Association and other organizations, published evidencebased guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease (ASCVD).(1) Along with the guidelines, there was a special report summarizing the rationale and evidence base for the current quantitative risk assessment tools.(2) These newest iterations strength
Article By:
Director, Penn Preventive Cardiovascular Program
Medical Director
Penn Presbyterian Heart and Vascular Pavilion
Associate Professor of Clinical Medicine
Philadelphia, PA
Fellow-in-Training, Post-Graduate Year 5
Cardiovascular Medicine,
University of Pennsylvania
Philadelphia, PA
Loretta is a 60-year-old white woman with a past medical history significant for hypercholesterolemia, mitral regurgitation, hypertension, pregnancy-induced hypertension (twice) and a family history of premature coronary heart disease (her father had myocardial infarction at age 53). Recent clinical examination is noted below:
The patient has refused medical therapy for hypertension and does not even want to consider lipid-lowering therapy.
Article By:
Director, Cardiovascular Health and Lipidology
North Shore University Hospital
Manhasset, NY
Cardiology Fellow
Mount Sinai Beth Israel
New York, NY
Discuss this article at www.lipid.org/lipidspin
Article By:
Director, Cardiovascular Prevention
Christiana Care Health System
Newark, DE
Cardiology
Christiana Care Health System
Newark, DE
Christiana Care Health System
Newark, DE
Cardiology
Christiana Care Health System
Newark, DE
Discuss the article at www.lipid.org/lipidspin
Article By:
Heart and Vascular, Einstein Healthcare Network
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Thomas Jefferson University Hospital
Philadelphia, PA
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Discuss this article at www.lipid.org/lipidspan
Article By:
Director, Cardiovascular Prevention
Christiana Care Health System
Newark, DE
Christiana Care Health System
Newark, DE
Cardiology
Christiana Care Health System
Newark, DE
Cardiology
Christiana Care Health System
Newark, DE
Discuss this article at www.lipid.org/lipidspin
Article By:
Katz Preventive Cardiology Fellow
Division of Cardiology
Department of Medicine
Emory University School of Medicine
Atlanta, GA
Katz Preventive Cardiology Fellow
Division of Cardiology
Department of Medicine Emory University School of Medicine
Atlanta, GA
Katz Professor in Preventive Cardiology
Director, Emory Heart Disease Prevention Center
Professor of Global Health
Hubert Department of Global Health
Rollins School of Public Health at Emory University
Atlanta, GA
